Key result
Mean C-reactive protein levels were significantly higher in symptomatic versus asymptomatic patients with Brugada syndrome (2.4 vs 1.4 mg/L, P=0.003), with CRP ≥2 mg/L acting as an independent marker.
Why the study?
Are elevated C-reactive protein levels associated with symptomatic status in patients with Brugada syndrome?
Observational (n=54)
Are elevated C-reactive protein levels associated with symptomatic status in patients with Brugada syndrome?
Absolute Event Rate: 2.4% vs 1.4%
p-value: p=0.003
Elevated C-reactive protein levels (≥ 2 mg/L) are independently associated with a history of symptoms (syncope or aborted sudden death) in patients with Brugada syndrome.
No takes yet. Share an insight, caveat, or question.
CRP ≥2 mg/L may stratify symptomatic risk in Brugada syndrome; leaves open its prognostic value and therapeutic implications.
Bonny et al. (2011) conducted an observational in Brugada syndrome (n=54). Symptomatic status (syncope or aborted sudden death) vs. Asymptomatic status was evaluated on Mean CRP level (mg/L) (p=0.003). Mean C-reactive protein levels were significantly higher in symptomatic versus asymptomatic patients with Brugada syndrome (2.4 vs 1.4 mg/L, P=0.003), with CRP ≥2 mg/L acting as an independent marker.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: